James Veltmeyer
Chief Tech/Sci/R&D Officer at THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Net worth: 37 000 $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Timothy Dixon | M | 66 | 13 years | |
| Thomas Ichim | M | 49 | 8 years | |
| Feng Lin | M | 54 | 5 years | |
| Serena Robella | F | - | 4 years | |
| Famela Ramos | F | 48 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gerry B. Berg | M | 77 | 8 years | |
| Michael A. Beeuwsaert | M | - |
LXN Corp
 LXN Corp Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million. | 2 years |
| Hong Ma | M | 56 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 8 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James Veltmeyer
- Personal Network
